Aphranel® MagiCCrystal CaHA Filler Achieves EU MDR Certification as a Premium Regenerative Injectable ...Middle East

SHANGHAI, May 28, 2026 /PRNewswire/ -- Moyom Biotechnology announced that its premium regenerative aesthetics product, Aphranel® MagiCCrystal CaHA Filler officially achieved European Union Medical Device Regulation (EU MDR) certification on May 18, 2026, under the registered name "Calcium...

Hence then, the article about aphranel magiccrystal caha filler achieves eu mdr certification as a premium regenerative injectable was published today ( Thursday 28/05/2026 - 11:23 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Aphranel® MagiCCrystal CaHA Filler Achieves EU MDR Certification as a Premium Regenerative Injectable )

Also on site :

• The essentials in your ‘big shop’ set to cost even more thanks to the energy crisis
• Senior Ukrainian commander sees imminent ‘turning point’ in war
• Psychologist Says if You Have To Listen To Something While Walking, You Likely Have These 7 Traits